RPTX - Repare Therapeutics Inc.
IEX Last Trade
1.32
0.005 0.379%
Share volume: 7,738
Last Updated: Thu 26 Dec 2024 08:23:20 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.32
0.01
0.38%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-09 | 2023-02-28 | 2023-05-09 | 2023-08-09 | 2023-11-09 | 2024-02-28 | 2024-05-07 | |
| Total revenue | 679.000 K | 112.545 M | 18.198 M | 5.678 M | 30.249 M | 2.159 M | 13.047 M | 52.404 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 679.000 K | 112.545 M | 18.198 M | 5.678 M | 30.249 M | 2.159 M | 13.047 M | 52.404 M | |
| 16,475.11% | -83.83% | -68.80% | 432.74% | -92.86% | 504.31% | 301.66% | |||
| Operating expenses | 39.413 M | 39.146 M | 37.830 M | 40.359 M | 42.507 M | 40.577 M | 43.914 M | 41.588 M | |
| Selling general and admin | 7.938 M | 7.904 M | 7.939 M | 8.529 M | 8.719 M | 7.868 M | 8.648 M | 8.618 M | |
| Research and development | 31.475 M | 31.242 M | 29.891 M | 31.830 M | 33.788 M | 32.709 M | 35.266 M | 32.970 M | |
| Total expenses | 39.413 M | 39.146 M | 37.830 M | 40.359 M | 42.507 M | 40.577 M | 43.914 M | 41.588 M | |
| -0.68% | -3.36% | 6.69% | 5.32% | -4.54% | 8.22% | -5.30% | |||
| Operating income | -38.734 M | 73.399 M | -19.632 M | -34.681 M | -12.258 M | -38.418 M | -30.867 M | 10.816 M | |
| Ebit | -38.734 M | 73.399 M | -19.632 M | -34.681 M | -12.258 M | -38.418 M | -30.867 M | 10.816 M | |
| Pretax income | -38.060 M | 75.515 M | -16.630 M | -31.325 M | -8.836 M | -35.178 M | -27.840 M | 13.791 M | |
| -298.41% | -122.02% | 88.36% | -71.79% | 298.12% | -20.86% | -149.54% | |||
| Income tax | 33.000 K | 54.000 K | 15.028 M | 3.616 M | 3.110 M | -16.299 M | 190.000 K | 629.000 K | |
| Net income basic | -38.093 M | 75.461 M | -31.658 M | -34.941 M | -11.946 M | -18.879 M | -28.030 M | 13.162 M | |
| 298.10% | -141.95% | -10.37% | 65.81% | -58.04% | -48.47% | 146.96% | |||
| Net income | -38.093 M | 75.461 M | -31.658 M | -34.941 M | -11.946 M | -18.879 M | -28.030 M | 13.162 M | |
| 298.10% | -141.95% | -10.37% | 65.81% | -58.04% | -48.47% | 146.96% |